Skip to main content
. 2022 Jan 20;102:103591. doi: 10.1016/j.drugpo.2022.103591

Table 1.

Characteristics of adult exposures involving methadone reported to the National Poison Data System Pre- vs Post-intervention (March 16, 2020).

Nonmedical useN = 1123 (%)
P value Suspected attempted suicideN = 1067 (%)
P value Unknown reason N = 271 (%)
P value
Pre- Post- Pre- Post- Pre- Post-
N 539 584 0.14 532 535 0.02 128 143 0.45
Median age (years) 39 39 0.80 42 41 0.65 45 41 0.26
Male 321(59.6) 365 (62.5) 0.31 254 (47.7) 242 (45.2) 0.41 60 (46.9) 75 (52.4) 0.36
Methadone-only 216(40.1) 237 (40.6) 0.86 121 (22.7) 139 (26.0) 0.22 54 (42.2) 61 (42.7) 0.94
THERAPIES
Naloxone administered 295(54.7) 301 (51.5) 0.29 250 (47.0) 252 (47.1) 0.97 80 (62.5) 73 (51) 0.06
Intubation/ventilator 36 (6.7) 34 (5.8) 0.55 82 (15.4) 69 (12.9) 0.24 28 (21.9) 24 (16.8) 0.29
Vasopressors administered 10 (1.9) 15 (2.6) 0.42 22 (4.1) 20 (3.7) 0.74 5 (3.9) 4 (2.8) 0.61
DISPOSITIONS
Treated & released from ED 154 (28.6) 165 (28.3) 102 (19.2) 88 (16.4) 15 (11.7) 24 (16.8)
Admitted non-critical care 107 (19.9) 142 (24.3) 104 (19.5) 135 (25.2) 21 (16.4) 34 (23.8)
Admitted critical care 158 (29.3) 148 (25.3) 235 (44.2) 210 (39.3) 67 (52.3) 53 (37.1)
Admitted psychiatry 16 (3.0) 8 (1.4) 57 (10.7) 69 (12.9) 9 (7) 2 (1.4)
Lost to follow up 104 (19.3) 121 (20.7) 0.10 34 (6.4%) 33 (6.2%) 0.10 16 (12.5) 30 (20.1) <0.05
MEDICAL OUTCOMES
Not followed/no effect 48 (8.9) 55 (9.4) 45 (8.5) 52 (9.7) 10 (7.8) 10 (7.0)
Minor effect 60 (11.1) 72 (12.3) 65 (12.2) 66 (12.3) 9 (7) 7 (4.9)
Moderate effect 201(37.3) 218 (37.3) 238 (44.7) 228 (42.6) 58 (45.3) 58 (40.6)
Major effect 162(30.1) 177 (30.3) 151 (28.4) 163 (30.5) 43 (33.6) 45 (31.5)
Death 9 (1.7) 7 (1.2) 11 (2.1) 3 (0.6) 0 (0) 3 (2.1)
Unknown outcome 59 (10.9) 55 (9.4) 0.92 22 (4.1) 23 (4.3) 0.22 8 (6.3) 20 (14) 0.44

Nonmedical use: exposure resulting from the intentional improper or incorrect use of a substance where the patient was likely attempting to gain a high, euphoric effect or some other psychotropic effect, including recreational use of a substance for any effect (e.g. using recreational drugs) OR exposure resulting from intentional improper or incorrect use of a substance for reasons other than the pursuit of psychotropic effect (e.g. person deliberately increases the dosage of a medication to enhance therapeutic effect, overuse of a substance to perform better).